FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Articles|September 29, 2021
COVID-19 Updates: Delta Variant, US Vaccinations, & Global Data as of September 29, 2021
Author(s)Sydney Jennings
Advertisement
How widespread is the Delta variant (B.1.617.2) in the US?
According to early estimates from the
The CDC estimates as of September 21, 2021, the 5 states with the highest unweighted proportion of new cases attributed to the SARS-CoV-2 Delta variant are:
1. Vermont: 99.58%
2. District of Columbia: 99.21%
3. Washington: 98.68%
4. Minnesota: 98.66%
5. New Hampshire: 98.62%
2. District of Columbia: 99.21%
3. Washington: 98.68%
4. Minnesota: 98.66%
5. New Hampshire: 98.62%
How many people in the US have been vaccinated against COVID-19?
According to the CDC as of today, September 29, 2021, at 8:40 PM, EDT:
• 64.5% of total US population has received at least 1 dose
• 55.5% of total US population is fully vaccinated
• 55.5% of total US population is fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Vermont: 69.4%
2. Connecticut: 68.6%
3. Maine: 68.5%
4. Rhode Island: 68.2%
5. Massachusetts: 67.9%
2. Connecticut: 68.6%
3. Maine: 68.5%
4. Rhode Island: 68.2%
5. Massachusetts: 67.9%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, September 29, 2021 at 4:21 PM, EDT, there have been:
• 43 333 586 confirmed cases and
• 694 864 deaths
• 694 864 deaths
The 5 states with the highest total confirmed cases are:
1. California: 4 709 088
2. Texas: 4 056 963
3. Florida: 3 582 807
4. New York: 2 421 755
5. Illinois: 1 624 164
2. Texas: 4 056 963
3. Florida: 3 582 807
4. New York: 2 421 755
5. Illinois: 1 624 164
Deaths: California has the highest number of deaths due to COVID-19 with 68 943 reported fatalities, followed by Texas with 64 843 and New York with 55 310.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 233 114 589 confirmed cases, 4 771 069 deaths, and 6 197 839 801 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The FDA accepted Bayer's sNDA and granted Priority Review to elinzanetant for vasomotor symptoms in women on endocrine therapy for HR+ breast cancer.
The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
2
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
3
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
4
Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
5